Previous antibiotic use and the development of Kawasaki disease: a matched pair case-control study

Mitsuharu Fukazawa1,2, Mitsuru Fukazawa1,2, Etsuro Nanishi2

  • 1Fukazawa Pediatric Clinic, Fukuoka, Japan.

Insights

Previous antibiotic use significantly increases Kawasaki disease (KD) risk in children. Antibiotics may alter gut microbiota, contributing to KD development and vasculitis.

Area of Science:

  • Pediatric Rheumatology
  • Microbiome Research
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) is a critical pediatric illness causing systemic vasculitis with unknown etiology.
  • Altered gut microbiota are increasingly recognized as potential contributors to KD pathogenesis.

Purpose of the Study:

  • To investigate factors associated with intestinal dysbiosis in children with Kawasaki disease.
  • To identify potential triggers for KD development.

Main Methods:

  • An age- and gender-matched case-control study involving 50 KD patients and 200 controls.
  • Conditional multivariable logistic regression analysis to determine associations.

Main Results:

  • Previous antibiotic administration was strongly associated with KD onset (OR 11.7, P < 0.0001).
  • Cesarean birth was an additional risk factor in infants under 12 months (OR 8.0, P = 0.005).
  • Breastfeeding and group nursery attendance were not significant factors.

Conclusions:

  • Previous antibiotic exposure is a significant risk factor for Kawasaki disease.
  • Antibiotics may promote KD by negatively impacting the gut microbiota in young children.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
334
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
210
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Criteria for Causality: Bradford Hill Criteria - I01:30

Criteria for Causality: Bradford Hill Criteria - I

The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples:
916